NAPLEX (North American Pharmacist Licensure Examination) Practice Exam

Disable ads (and more) with a membership for a one time $4.99 payment

Ace your North American Pharmacist Licensure Examination (NAPLEX) with our comprehensive practice test. Features include interactive flashcards, multiple-choice questions, with detailed hints and explanations. Fast-track your pharmacy career today!

Practice this question and more.

Which medication does not belong to the treatment options for CA-MRSA SSTI?

SMX/TMP
Linezolid
Mupirocin
Clindamycin

The correct answer is: Mupirocin

Mupirocin does not belong to the treatment options for CA-MRSA (Community-Associated Methicillin-Resistant Staphylococcus aureus) Skin and Soft Tissue Infections (SSTIs) because it is an antibiotic primarily used topically to eradicate Staphylococcus aureus from the nasal mucosa to prevent transmission. SMX/TMP (Sulfamethoxazole/Trimethoprim), Linezolid, and Clindamycin are all appropriate treatments for CA-MRSA SSTIs due to their efficacy against MRSA strains. SMX/TMP and Clindamycin are commonly used oral antibiotics, while Linezolid is an IV and oral agent used for MRSA infections when other options are not suitable.